Polyrizon (PLRZ) Stock Price, News & Analysis

Company Overview

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Key Stats

• Today's Range: $1.07 to $1.10
• 50-Day Range: $0.96 to $1.46
• 52-Week Range: $0.55 to $1,200.00
• Volume: 236,196 shs
• Average Volume: 2.67 million shs
• Market Capitalization: $6.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

PLRZ Stock Analysis - Frequently Asked Questions

How have PLRZ shares performed this year?

Polyrizon's stock was trading at $542.50 at the beginning of the year. Since then, PLRZ stock has decreased by 99.8% and is now trading at $1.09.

When did Polyrizon's stock split?

Polyrizon's stock reverse split on Tuesday, May 27th 2025.A 1-250 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

When did Polyrizon IPO?

Polyrizon (PLRZ) raised $4 million in an IPO on Tuesday, October 29th 2024. The company issued 958,903 shares at a price of $4.38 per share.

How do I buy shares of Polyrizon?

Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PLRZ
• Previous Symbol: NASDAQ:PLRZ
• CIK: 1893645
• Web: www.polyrizon-biotech.com
• Phone: 972-55-433-5665
• Fax: N/A
• Employees: N/A
• Year Founded: 2005

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 44.04
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $315.07 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 5,990,000
• Free Float: N/A
• Market Cap: $6.53 million
• Optionable: N/A
• Beta: N/A